English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Press release submission
| Aug 13, 2021
Leading Diabetes Advocacy Groups Urge CDC to Include Americans with Diabetes in Those Prioritized for COVID-19 Vaccine Boosters
Press release submission
| Aug 7, 2021
New Two-Year Data Showed Bimekizumab Maintained High Levels of Skin Clearance in Patients with Moderate to Severe Plaque Psoriasis
Press release submission
| Aug 7, 2021
Mental health patients will answer when asked about firearms
Press release submission
| Jul 31, 2021
Multiple Myeloma Patients Display Weakened Antibody Responses to mRNA COVID Vaccines
Press release submission
| Jul 31, 2021
New Study Aims to Show Effectiveness of CRT-D Technology for Heart Failure Patients with Atrial Fibrillation
Press release submission
| Jul 24, 2021
FDA Stops Emergency Use Authorization Review of SQI Diagnostics RALI-Dx™ IL-6 Severity Triage Test for COVID-19 Patients
Press release submission
| Jul 24, 2021
DALVANCE® (dalbavancin) Receives FDA Approval to Treat Acute Bacterial Skin and Skin Structure Infections in Pediatric Patients
Press release submission
| Jul 15, 2021
Patient Impact Statement: FDA Approval of Kerendia to Help Slow Kidney Disease and Failure Associated with Type 2 Diabetes
Trending
+
Pharmaceuticals
Patient Daily
| Sep 12, 2025
Taxpayers Protection Alliance says 340B program is driving up taxpayer costs
« First
«
…
8
9
10
11
12
13
14
…
»
Last »